CIRM Funded Clinical Trials
Phase I/II Clinical Trial for CMT4J
Disease Area:
Developmental Disorders, Genetic Disorder, Other
Trial Sponsor:
Elpida Therapeutics
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A
